These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
149 related items for PubMed ID: 2516887
1. Reduced deposition of aluminium in trabecular bone of uraemic rats treated with dihydroxylated vitamin D metabolites. Ittel TH, Hofstädter F, Gladziwa U, Sieberth HG. Nephrol Dial Transplant; 1989; 4(11):957-65. PubMed ID: 2516887 [Abstract] [Full Text] [Related]
2. Effects of 1 alpha,25- and 24R,25-dihydroxyvitamin D3 on aluminum-induced rickets in growing uremic rats. Vukicević S, Krempien B, Stavljenić A. J Bone Miner Res; 1987 Dec; 2(6):533-45. PubMed ID: 3502683 [Abstract] [Full Text] [Related]
9. The effect of hemodialysis, vitamin D metabolites and renal transplantation on the skeletal demineralization associated with renal osteodystrophy: a computerized histomorphometric analysis. Main J, Velasco N, Catto GR, Fraser RA, Edward N, Adami S, O'Riordan JL. Clin Nephrol; 1986 Dec; 26(6):279-87. PubMed ID: 3542321 [Abstract] [Full Text] [Related]
13. Influence of biochemical and hormonal factors on the bone histomorphometric features of uraemic patients. Fournier A, Sebert JL, Fohrer P, Moriniere P, Lambrey G, Herve MA, Leflon P, Gueris J, Garabedian M. Proc Eur Dial Transplant Assoc Eur Ren Assoc; 1985 Dec; 21():415-20. PubMed ID: 3991534 [Abstract] [Full Text] [Related]
14. Treatment of hemodialysis bone disease with 24,25-(OH)2D3 and 1,25-(OH)2D3 alone or in combination. Dunstan CR, Hills E, Norman AW, Bishop JE, Mayer E, Wong SY, Eade Y, Johnson JR, George CR, Collett P. Miner Electrolyte Metab; 1985 Dec; 11(6):358-68. PubMed ID: 3877862 [Abstract] [Full Text] [Related]
15. Assessment of combined 24,25(OH)2D3 and 1 alpha (OH)D3 therapy for bone disease in dialysis patients. Popovtzer MM, Levi J, Bar-Khayim Y, Shasha SM, Boner G, Bernheim J, Chaimovitz C, Rubinger D, Gafter U, Gazit D. Bone; 1992 Dec; 13(5):369-77. PubMed ID: 1419378 [Abstract] [Full Text] [Related]
16. 24R,25-dihydroxyvitamin D3: an essential vitamin D3 metabolite for both normal bone integrity and healing of tibial fracture in chicks. Seo EG, Einhorn TA, Norman AW. Endocrinology; 1997 Sep; 138(9):3864-72. PubMed ID: 9275076 [Abstract] [Full Text] [Related]
17. Activity of ornithine decarboxylase and creatine kinase in soft and hard tissue of vitamin D-deficient chicks following parenteral application of 1,25-dihydroxyvitamin D3 or 24R,25-dihydroxyvitamin D3. Ittel TH, Ross FP, Norman AW. J Bone Miner Res; 1986 Feb; 1(1):23-31. PubMed ID: 3509739 [Abstract] [Full Text] [Related]
18. Effect of dihydroxylated metabolites of vitamin D3 on calcium absorption in uraemic man. Muirhead N, Catto GR, Gvozdanovic S, Gvozdanovic D, Edward N. Clin Sci (Lond); 1981 Dec; 61(6):723-7. PubMed ID: 6975197 [Abstract] [Full Text] [Related]
19. 24R,25-dihydroxyvitamin D3 promotes bone formation without causing excessive resorption in hypophosphatemic mice. Ono T, Tanaka H, Yamate T, Nagai Y, Nakamura T, Seino Y. Endocrinology; 1996 Jun; 137(6):2633-7. PubMed ID: 8641218 [Abstract] [Full Text] [Related]
20. Developmental changes in the responsiveness of rat kidney to vitamin D metabolites. Sömjen D, Weisman Y, Berger E, Earon Y, Kaye AM, Binderman I. Endocrinology; 1986 Jan; 118(1):354-9. PubMed ID: 3000745 [Abstract] [Full Text] [Related] Page: [Next] [New Search]